

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.81964858 |
| 2 | keratinization (GO:0031424) | 6.18440171 |
| 3 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.72368529 |
| 4 | surfactant homeostasis (GO:0043129) | 5.24585585 |
| 5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.78258239 |
| 6 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.77235004 |
| 7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.56056401 |
| 8 | sarcomere organization (GO:0045214) | 4.44629003 |
| 9 | chemical homeostasis within a tissue (GO:0048875) | 4.40285892 |
| 10 | establishment of skin barrier (GO:0061436) | 4.33168611 |
| 11 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.30614850 |
| 12 | cardiac myofibril assembly (GO:0055003) | 4.29910587 |
| 13 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.24059265 |
| 14 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.03096635 |
| 15 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.98292689 |
| 16 | desmosome organization (GO:0002934) | 3.97453847 |
| 17 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.90851151 |
| 18 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.82216204 |
| 19 | cardiac muscle contraction (GO:0060048) | 3.76931063 |
| 20 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.73931797 |
| 21 | cell communication involved in cardiac conduction (GO:0086065) | 3.73916506 |
| 22 | myofibril assembly (GO:0030239) | 3.73321210 |
| 23 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.71342702 |
| 24 | C4-dicarboxylate transport (GO:0015740) | 3.61011146 |
| 25 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.59346398 |
| 26 | auditory behavior (GO:0031223) | 3.58887051 |
| 27 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.54901048 |
| 28 | activated T cell proliferation (GO:0050798) | 3.53123873 |
| 29 | ATP synthesis coupled proton transport (GO:0015986) | 3.52462767 |
| 30 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.52462767 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.50123451 |
| 32 | negative regulation by host of viral transcription (GO:0043922) | 3.49175539 |
| 33 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.47352530 |
| 34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.46505953 |
| 35 | T cell migration (GO:0072678) | 3.41939382 |
| 36 | neurotransmitter uptake (GO:0001504) | 3.40794350 |
| 37 | heart trabecula formation (GO:0060347) | 3.40390234 |
| 38 | respiratory electron transport chain (GO:0022904) | 3.39698540 |
| 39 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.37586847 |
| 40 | regulation of relaxation of muscle (GO:1901077) | 3.33763841 |
| 41 | regulation of cardioblast differentiation (GO:0051890) | 3.32910200 |
| 42 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.32578566 |
| 43 | regulation of actin filament-based movement (GO:1903115) | 3.31968580 |
| 44 | electron transport chain (GO:0022900) | 3.30663708 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.27381825 |
| 46 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.26161984 |
| 47 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.25007970 |
| 48 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.23795420 |
| 49 | tricarboxylic acid cycle (GO:0006099) | 3.21581525 |
| 50 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.19416386 |
| 51 | cell communication by electrical coupling (GO:0010644) | 3.14061333 |
| 52 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.13813795 |
| 53 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.13721576 |
| 54 | fatty acid transmembrane transport (GO:1902001) | 3.13164800 |
| 55 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.12632952 |
| 56 | regulation of water loss via skin (GO:0033561) | 3.11034227 |
| 57 | cellular response to interleukin-15 (GO:0071350) | 3.09813928 |
| 58 | cardiac muscle cell development (GO:0055013) | 3.08391458 |
| 59 | postsynaptic membrane organization (GO:0001941) | 3.08191891 |
| 60 | regulation of membrane repolarization (GO:0060306) | 3.07686859 |
| 61 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.07385780 |
| 62 | regulation of endothelial cell differentiation (GO:0045601) | 3.07135890 |
| 63 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.06982735 |
| 64 | actomyosin structure organization (GO:0031032) | 3.06848067 |
| 65 | eosinophil chemotaxis (GO:0048245) | 3.06440060 |
| 66 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.05599012 |
| 67 | actin-myosin filament sliding (GO:0033275) | 3.05377542 |
| 68 | muscle filament sliding (GO:0030049) | 3.05377542 |
| 69 | plasma membrane repair (GO:0001778) | 3.04456220 |
| 70 | mechanosensory behavior (GO:0007638) | 3.04327846 |
| 71 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.04003212 |
| 72 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.03223777 |
| 73 | aggressive behavior (GO:0002118) | 3.02889663 |
| 74 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.02648707 |
| 75 | carnitine shuttle (GO:0006853) | 3.00576967 |
| 76 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.98929130 |
| 77 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.97501662 |
| 78 | relaxation of cardiac muscle (GO:0055119) | 2.97497583 |
| 79 | macrophage chemotaxis (GO:0048246) | 2.96710022 |
| 80 | positive regulation of lymphocyte migration (GO:2000403) | 2.93312549 |
| 81 | fatty acid beta-oxidation (GO:0006635) | 2.92105357 |
| 82 | regulation of striated muscle contraction (GO:0006942) | 2.89390881 |
| 83 | regulation of calcium-mediated signaling (GO:0050848) | 2.89214306 |
| 84 | cardiac cell development (GO:0055006) | 2.89157749 |
| 85 | positive T cell selection (GO:0043368) | 2.88994385 |
| 86 | cellular response to nitric oxide (GO:0071732) | 2.88779131 |
| 87 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.88309615 |
| 88 | cardiac muscle hypertrophy (GO:0003300) | 2.87823379 |
| 89 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.87767854 |
| 90 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.86502372 |
| 91 | regulation of the force of heart contraction (GO:0002026) | 2.85721744 |
| 92 | adult heart development (GO:0007512) | 2.85617651 |
| 93 | regulation of vasculogenesis (GO:2001212) | 2.84909613 |
| 94 | cellular response to reactive nitrogen species (GO:1902170) | 2.83306163 |
| 95 | cardiac muscle cell action potential (GO:0086001) | 2.80787468 |
| 96 | muscle tissue morphogenesis (GO:0060415) | 2.78990341 |
| 97 | cardiac conduction (GO:0061337) | 2.77755928 |
| 98 | striated muscle hypertrophy (GO:0014897) | 2.77269914 |
| 99 | cytidine metabolic process (GO:0046087) | 2.76235283 |
| 100 | cytidine catabolic process (GO:0006216) | 2.76235283 |
| 101 | cytidine deamination (GO:0009972) | 2.76235283 |
| 102 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.75260499 |
| 103 | eosinophil migration (GO:0072677) | 2.74842062 |
| 104 | regulation of cell communication by electrical coupling (GO:0010649) | 2.74749103 |
| 105 | regulation of sarcomere organization (GO:0060297) | 2.74653193 |
| 106 | regulation of regulatory T cell differentiation (GO:0045589) | 2.74288885 |
| 107 | L-amino acid import (GO:0043092) | 2.71576798 |
| 108 | membrane repolarization during action potential (GO:0086011) | 2.70558416 |
| 109 | regulation of heart rate (GO:0002027) | 2.69986438 |
| 110 | striated muscle contraction (GO:0006941) | 2.69627134 |
| 111 | negative regulation of T cell apoptotic process (GO:0070233) | 2.69470421 |
| 112 | negative regulation of protein localization to cell surface (GO:2000009) | 2.69074110 |
| 113 | gamma-aminobutyric acid transport (GO:0015812) | 2.68061411 |
| 114 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.67442066 |
| 115 | regulation of cardiac muscle contraction (GO:0055117) | 2.66347830 |
| 116 | potassium ion export (GO:0071435) | 2.66195429 |
| 117 | regulation of B cell differentiation (GO:0045577) | 2.66121747 |
| 118 | regulation of activation of Janus kinase activity (GO:0010533) | 2.64447362 |
| 119 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.63325382 |
| 120 | regulation of T cell chemotaxis (GO:0010819) | 2.60885942 |
| 121 | positive regulation of T cell chemotaxis (GO:0010820) | 2.60885942 |
| 122 | actin-mediated cell contraction (GO:0070252) | 2.60853153 |
| 123 | 2-oxoglutarate metabolic process (GO:0006103) | 2.59745838 |
| 124 | lymphocyte chemotaxis (GO:0048247) | 2.58876947 |
| 125 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.58346288 |
| 126 | fatty acid catabolic process (GO:0009062) | 2.57369942 |
| 127 | response to nitric oxide (GO:0071731) | 2.57047978 |
| 128 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.54996791 |
| 129 | positive thymic T cell selection (GO:0045059) | 2.54807705 |
| 130 | hormone catabolic process (GO:0042447) | 2.54762988 |
| 131 | lysine catabolic process (GO:0006554) | 2.54532800 |
| 132 | lysine metabolic process (GO:0006553) | 2.54532800 |
| 133 | regulation of skeletal muscle contraction (GO:0014819) | 2.54336855 |
| 134 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.54277955 |
| 135 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.54277955 |
| 136 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.53643649 |
| 137 | lipid oxidation (GO:0034440) | 2.53558364 |
| 138 | negative T cell selection (GO:0043383) | 2.52886612 |
| 139 | neuron cell-cell adhesion (GO:0007158) | 2.52543580 |
| 140 | fatty acid oxidation (GO:0019395) | 2.52389627 |
| 141 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.51424318 |
| 142 | one-carbon compound transport (GO:0019755) | 2.49483609 |
| 143 | muscle hypertrophy (GO:0014896) | 2.49466292 |
| 144 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.49231233 |
| 145 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.48795946 |
| 146 | hemidesmosome assembly (GO:0031581) | 2.47668051 |
| 147 | regulation of interleukin-8 secretion (GO:2000482) | 2.47565792 |
| 148 | aspartate family amino acid catabolic process (GO:0009068) | 2.46646741 |
| 149 | ethanol metabolic process (GO:0006067) | 2.46545062 |
| 150 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.45795454 |
| 151 | detection of light stimulus involved in visual perception (GO:0050908) | 2.45795454 |
| 152 | fatty acid elongation (GO:0030497) | 2.45364850 |
| 153 | membrane repolarization (GO:0086009) | 2.44636824 |
| 154 | positive regulation of defense response to virus by host (GO:0002230) | 2.44521625 |
| 155 | multicellular organismal water homeostasis (GO:0050891) | 2.44052990 |
| 156 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.42787728 |
| 157 | heart contraction (GO:0060047) | 2.42203880 |
| 158 | heart process (GO:0003015) | 2.42203880 |
| 159 | cellular potassium ion homeostasis (GO:0030007) | 2.41439156 |
| 160 | ethanol oxidation (GO:0006069) | 2.41274449 |
| 161 | negative regulation of viral genome replication (GO:0045071) | 2.40782437 |
| 162 | short-chain fatty acid metabolic process (GO:0046459) | 2.40631757 |
| 163 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.40536133 |
| 164 | DNA demethylation (GO:0080111) | 2.40326761 |
| 165 | cellular ketone body metabolic process (GO:0046950) | 2.39635862 |
| 166 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.38858024 |
| 167 | positive regulation of B cell differentiation (GO:0045579) | 2.38310949 |
| 168 | keratinocyte differentiation (GO:0030216) | 2.38127280 |
| 169 | response to auditory stimulus (GO:0010996) | 2.38115977 |
| 170 | presynaptic membrane assembly (GO:0097105) | 2.37942732 |
| 171 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.37843684 |
| 172 | response to interleukin-15 (GO:0070672) | 2.37641137 |
| 173 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.36100306 |
| 174 | blood vessel maturation (GO:0001955) | 2.35898497 |
| 175 | lymphangiogenesis (GO:0001946) | 2.35311759 |
| 176 | regulation of female receptivity (GO:0045924) | 2.35169476 |
| 177 | neuronal action potential propagation (GO:0019227) | 2.34402142 |
| 178 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.34046842 |
| 179 | actin nucleation (GO:0045010) | 2.32630507 |
| 180 | negative regulation of mast cell activation (GO:0033004) | 2.32485809 |
| 181 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.31904399 |
| 182 | detection of calcium ion (GO:0005513) | 2.31873739 |
| 183 | positive regulation of cell killing (GO:0031343) | 2.30802597 |
| 184 | lymphocyte migration (GO:0072676) | 2.30546326 |
| 185 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.29809381 |
| 186 | water homeostasis (GO:0030104) | 2.29471941 |
| 187 | acidic amino acid transport (GO:0015800) | 2.27012447 |
| 188 | positive regulation of amino acid transport (GO:0051957) | 2.26993193 |
| 189 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.26782797 |
| 190 | hair cycle (GO:0042633) | 2.26451902 |
| 191 | molting cycle (GO:0042303) | 2.26451902 |
| 192 | potassium ion import (GO:0010107) | 2.24242808 |
| 193 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.22568657 |
| 194 | primary amino compound metabolic process (GO:1901160) | 2.21633603 |
| 195 | synaptic vesicle exocytosis (GO:0016079) | 2.20603235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.33305444 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.75945798 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 2.65102622 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.59939632 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.56015478 |
| 6 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.50269779 |
| 7 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.45430522 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.43618836 |
| 9 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.38795720 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.37802411 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.32561911 |
| 12 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.30485303 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.29671021 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.26034724 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.23518722 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.20878549 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.16362564 |
| 18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.13768700 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.04951378 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.04699289 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04645503 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.02341164 |
| 23 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.97556788 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.94944772 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.94663790 |
| 26 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.94417416 |
| 27 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.94417416 |
| 28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.89077313 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.86006542 |
| 30 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.85632658 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.82809794 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.80503902 |
| 33 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.80314760 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.80204693 |
| 35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.78853379 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.76559061 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.66122929 |
| 38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.61825394 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.58361445 |
| 40 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53066220 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.52837920 |
| 42 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.52509668 |
| 43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.51231128 |
| 44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.50481371 |
| 45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.47904400 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46411300 |
| 47 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.46140637 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44379827 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.43216909 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42263118 |
| 51 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.39961714 |
| 52 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.38161671 |
| 53 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.36517751 |
| 54 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.36517751 |
| 55 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.36391146 |
| 56 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.35645559 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34881588 |
| 58 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.34583707 |
| 59 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33267036 |
| 60 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.32649042 |
| 61 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31192831 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.30504608 |
| 63 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.29800566 |
| 64 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.29674909 |
| 65 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.29324640 |
| 66 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.28015450 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27743812 |
| 68 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.27470231 |
| 69 | RXR_22108803_ChIP-Seq_LS180_Human | 1.27411441 |
| 70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.27379345 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25826721 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.24571881 |
| 73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22429846 |
| 74 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.22410680 |
| 75 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21501631 |
| 76 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21232892 |
| 77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21138661 |
| 78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20421515 |
| 79 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20147346 |
| 80 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.20038553 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19638051 |
| 82 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19018406 |
| 83 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18451885 |
| 84 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18284393 |
| 85 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.17809714 |
| 86 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17184566 |
| 87 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.16757197 |
| 88 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.16664651 |
| 89 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15769099 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15260976 |
| 91 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.15013869 |
| 92 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.13920262 |
| 93 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.13920262 |
| 94 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.13847926 |
| 95 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13591962 |
| 96 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13591962 |
| 97 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13400116 |
| 98 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.12917449 |
| 99 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.12032155 |
| 100 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11902789 |
| 101 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.11632434 |
| 102 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.09896624 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.08437836 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08434595 |
| 105 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.07368234 |
| 106 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07365086 |
| 107 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07055432 |
| 108 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06425185 |
| 109 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06343532 |
| 110 | MYB_26560356_Chip-Seq_TH2_Human | 1.06129958 |
| 111 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05849618 |
| 112 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05582138 |
| 113 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05455383 |
| 114 | EWS_26573619_Chip-Seq_HEK293_Human | 1.05311560 |
| 115 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04968437 |
| 116 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04622420 |
| 117 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.04495475 |
| 118 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04253631 |
| 119 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.04083312 |
| 120 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04068276 |
| 121 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.03611969 |
| 122 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03380103 |
| 123 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03380103 |
| 124 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02623894 |
| 125 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02484873 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02427082 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02427082 |
| 128 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.02169181 |
| 129 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.02074451 |
| 130 | AR_20517297_ChIP-Seq_VCAP_Human | 1.01803115 |
| 131 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01784921 |
| 132 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01767513 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00628112 |
| 134 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00101119 |
| 135 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99585239 |
| 136 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98886186 |
| 137 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98775402 |
| 138 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.97337792 |
| 139 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96813270 |
| 140 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96751617 |
| 141 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.96508561 |
| 142 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.96455675 |
| 143 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96144091 |
| 144 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95439163 |
| 145 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.95335427 |
| 146 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.95304534 |
| 147 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94694704 |
| 148 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94579952 |
| 149 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.94496211 |
| 150 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93069414 |
| 151 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.92839616 |
| 152 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.92821047 |
| 153 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92383624 |
| 154 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.92059723 |
| 155 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91707467 |
| 156 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.90333459 |
| 157 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.88053406 |
| 158 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87389537 |
| 159 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.87190907 |
| 160 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86672117 |
| 161 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.86375669 |
| 162 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86316506 |
| 163 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85788934 |
| 164 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.85587538 |
| 165 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85159896 |
| 166 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.84992040 |
| 167 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84216720 |
| 168 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84075562 |
| 169 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.83181028 |
| 170 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82943739 |
| 171 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82930390 |
| 172 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82624345 |
| 173 | KDM2B_26808549_Chip-Seq_K562_Human | 0.80110901 |
| 174 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79664464 |
| 175 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.77435168 |
| 176 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.76981070 |
| 177 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.76826428 |
| 178 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.76122102 |
| 179 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.75560136 |
| 180 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.75377902 |
| 181 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75191525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.49860736 |
| 2 | MP0004084_abnormal_cardiac_muscle | 4.41583353 |
| 3 | MP0005671_abnormal_response_to | 3.58224336 |
| 4 | MP0004215_abnormal_myocardial_fiber | 3.43198545 |
| 5 | MP0004036_abnormal_muscle_relaxation | 3.27584835 |
| 6 | MP0003880_abnormal_central_pattern | 2.96886003 |
| 7 | MP0000751_myopathy | 2.91806317 |
| 8 | MP0010368_abnormal_lymphatic_system | 2.82573048 |
| 9 | MP0005330_cardiomyopathy | 2.73275973 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.70561138 |
| 11 | MP0004782_abnormal_surfactant_physiolog | 2.60132226 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.48867877 |
| 13 | MP0001984_abnormal_olfaction | 2.48168879 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 2.47066318 |
| 15 | * MP0002972_abnormal_cardiac_muscle | 2.46417867 |
| 16 | MP0002736_abnormal_nociception_after | 2.46033867 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.44499284 |
| 18 | MP0005083_abnormal_biliary_tract | 2.40748702 |
| 19 | MP0003011_delayed_dark_adaptation | 2.40473228 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 2.38065932 |
| 21 | MP0003646_muscle_fatigue | 2.33886726 |
| 22 | MP0006138_congestive_heart_failure | 2.32719592 |
| 23 | MP0001879_abnormal_lymphatic_vessel | 2.24302254 |
| 24 | * MP0001544_abnormal_cardiovascular_syste | 2.19744342 |
| 25 | * MP0005385_cardiovascular_system_phenoty | 2.19744342 |
| 26 | MP0000569_abnormal_digit_pigmentation | 2.18635429 |
| 27 | MP0008775_abnormal_heart_ventricle | 2.17125300 |
| 28 | MP0009745_abnormal_behavioral_response | 2.17034217 |
| 29 | MP0008875_abnormal_xenobiotic_pharmacok | 2.16137779 |
| 30 | MP0003828_pulmonary_edema | 2.11036559 |
| 31 | MP0000749_muscle_degeneration | 2.08708080 |
| 32 | MP0004130_abnormal_muscle_cell | 2.07286109 |
| 33 | MP0009046_muscle_twitch | 2.05453334 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 2.02891440 |
| 35 | MP0001958_emphysema | 2.02616163 |
| 36 | * MP0003137_abnormal_impulse_conducting | 1.98698463 |
| 37 | MP0004484_altered_response_of | 1.97555089 |
| 38 | MP0004885_abnormal_endolymph | 1.97305729 |
| 39 | MP0005360_urolithiasis | 1.94883510 |
| 40 | MP0004859_abnormal_synaptic_plasticity | 1.89653437 |
| 41 | MP0002064_seizures | 1.86844186 |
| 42 | * MP0004087_abnormal_muscle_fiber | 1.86663711 |
| 43 | MP0004085_abnormal_heartbeat | 1.85645741 |
| 44 | MP0001486_abnormal_startle_reflex | 1.85394213 |
| 45 | MP0005551_abnormal_eye_electrophysiolog | 1.85386098 |
| 46 | MP0002095_abnormal_skin_pigmentation | 1.85144085 |
| 47 | MP0002272_abnormal_nervous_system | 1.82607034 |
| 48 | MP0003635_abnormal_synaptic_transmissio | 1.79175086 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.77057721 |
| 50 | * MP0005620_abnormal_muscle_contractility | 1.71239658 |
| 51 | * MP0010630_abnormal_cardiac_muscle | 1.71098078 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.69446960 |
| 53 | MP0004510_myositis | 1.65196065 |
| 54 | MP0002638_abnormal_pupillary_reflex | 1.62933111 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.62446299 |
| 56 | MP0001502_abnormal_circadian_rhythm | 1.62191883 |
| 57 | MP0006072_abnormal_retinal_apoptosis | 1.56206549 |
| 58 | MP0006082_CNS_inflammation | 1.56168833 |
| 59 | MP0002796_impaired_skin_barrier | 1.55619822 |
| 60 | MP0002063_abnormal_learning/memory/cond | 1.55339108 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.54704758 |
| 62 | MP0001835_abnormal_antigen_presentation | 1.54132935 |
| 63 | MP0002572_abnormal_emotion/affect_behav | 1.53019485 |
| 64 | MP0001905_abnormal_dopamine_level | 1.52554297 |
| 65 | MP0005423_abnormal_somatic_nervous | 1.52409668 |
| 66 | MP0002733_abnormal_thermal_nociception | 1.51094877 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.51075953 |
| 68 | MP0003950_abnormal_plasma_membrane | 1.51044151 |
| 69 | MP0002148_abnormal_hypersensitivity_rea | 1.50876743 |
| 70 | MP0009785_altered_susceptibility_to | 1.47897408 |
| 71 | MP0008569_lethality_at_weaning | 1.47331958 |
| 72 | MP0001188_hyperpigmentation | 1.45910162 |
| 73 | MP0005365_abnormal_bile_salt | 1.42392213 |
| 74 | MP0000343_altered_response_to | 1.41205839 |
| 75 | MP0005253_abnormal_eye_physiology | 1.40451625 |
| 76 | MP0001970_abnormal_pain_threshold | 1.39500961 |
| 77 | MP0005165_increased_susceptibility_to | 1.37369690 |
| 78 | MP0003045_fibrosis | 1.37068448 |
| 79 | MP0006276_abnormal_autonomic_nervous | 1.34596956 |
| 80 | MP0003705_abnormal_hypodermis_morpholog | 1.34182328 |
| 81 | MP0001440_abnormal_grooming_behavior | 1.33754474 |
| 82 | MP0005000_abnormal_immune_tolerance | 1.33523585 |
| 83 | MP0003566_abnormal_cell_adhesion | 1.32248077 |
| 84 | MP0004272_abnormal_basement_membrane | 1.28303464 |
| 85 | MP0000750_abnormal_muscle_regeneration | 1.27457887 |
| 86 | MP0000015_abnormal_ear_pigmentation | 1.27113201 |
| 87 | MP0006036_abnormal_mitochondrial_physio | 1.27098801 |
| 88 | MP0004270_analgesia | 1.25348329 |
| 89 | MP0002876_abnormal_thyroid_physiology | 1.25190531 |
| 90 | MP0001800_abnormal_humoral_immune | 1.24535967 |
| 91 | MP0001790_abnormal_immune_system | 1.24420944 |
| 92 | MP0005387_immune_system_phenotype | 1.24420944 |
| 93 | MP0002127_abnormal_cardiovascular_syste | 1.22421390 |
| 94 | MP0004947_skin_inflammation | 1.21022576 |
| 95 | MP0009840_abnormal_foam_cell | 1.19515829 |
| 96 | MP0005025_abnormal_response_to | 1.19468383 |
| 97 | MP0002420_abnormal_adaptive_immunity | 1.19314038 |
| 98 | MP0003252_abnormal_bile_duct | 1.18145981 |
| 99 | MP0003633_abnormal_nervous_system | 1.16462094 |
| 100 | MP0002723_abnormal_immune_serum | 1.16292046 |
| 101 | MP0002067_abnormal_sensory_capabilities | 1.15173613 |
| 102 | MP0001819_abnormal_immune_cell | 1.13467521 |
| 103 | MP0002295_abnormal_pulmonary_circulatio | 1.13091968 |
| 104 | MP0005275_abnormal_skin_tensile | 1.12319769 |
| 105 | MP0005388_respiratory_system_phenotype | 1.11640207 |
| 106 | MP0002133_abnormal_respiratory_system | 1.11640207 |
| 107 | MP0008872_abnormal_physiological_respon | 1.10706569 |
| 108 | MP0005332_abnormal_amino_acid | 1.10681438 |
| 109 | MP0000920_abnormal_myelination | 1.10563175 |
| 110 | MP0009780_abnormal_chondrocyte_physiolo | 1.10284526 |
| 111 | MP0000383_abnormal_hair_follicle | 1.10128403 |
| 112 | MP0009333_abnormal_splenocyte_physiolog | 1.09870339 |
| 113 | MP0002132_abnormal_respiratory_system | 1.09569375 |
| 114 | * MP0002106_abnormal_muscle_physiology | 1.08544048 |
| 115 | MP0005075_abnormal_melanosome_morpholog | 1.06994115 |
| 116 | MP0003866_abnormal_defecation | 1.06736896 |
| 117 | MP0005645_abnormal_hypothalamus_physiol | 1.05952243 |
| 118 | MP0010329_abnormal_lipoprotein_level | 1.05269908 |
| 119 | MP0010678_abnormal_skin_adnexa | 1.04049547 |
| 120 | MP0004742_abnormal_vestibular_system | 1.03909023 |
| 121 | MP0005501_abnormal_skin_physiology | 1.03847948 |
| 122 | MP0010234_abnormal_vibrissa_follicle | 1.03371920 |
| 123 | MP0002118_abnormal_lipid_homeostasis | 1.03175353 |
| 124 | MP0000579_abnormal_nail_morphology | 1.02057265 |
| 125 | MP0003806_abnormal_nucleotide_metabolis | 1.01238037 |
| 126 | MP0005386_behavior/neurological_phenoty | 0.99646581 |
| 127 | MP0004924_abnormal_behavior | 0.99646581 |
| 128 | MP0000685_abnormal_immune_system | 0.99117357 |
| 129 | MP0004381_abnormal_hair_follicle | 0.97682295 |
| 130 | MP0000604_amyloidosis | 0.96490524 |
| 131 | MP0004858_abnormal_nervous_system | 0.96485478 |
| 132 | MP0002734_abnormal_mechanical_nocicepti | 0.95841217 |
| 133 | MP0004185_abnormal_adipocyte_glucose | 0.95796310 |
| 134 | MP0002557_abnormal_social/conspecific_i | 0.95553863 |
| 135 | MP0002229_neurodegeneration | 0.95475631 |
| 136 | MP0002822_catalepsy | 0.94407733 |
| 137 | MP0002269_muscular_atrophy | 0.93496836 |
| 138 | MP0000647_abnormal_sebaceous_gland | 0.91542094 |
| 139 | MP0009384_cardiac_valve_regurgitation | 0.91524168 |
| 140 | MP0003329_amyloid_beta_deposits | 0.91389366 |
| 141 | MP0003279_aneurysm | 0.91258936 |
| 142 | MP0001853_heart_inflammation | 0.90755416 |
| 143 | MP0002332_abnormal_exercise_endurance | 0.89963383 |
| 144 | MP0010386_abnormal_urinary_bladder | 0.89646004 |
| 145 | MP0004147_increased_porphyrin_level | 0.88996550 |
| 146 | MP0000230_abnormal_systemic_arterial | 0.88677665 |
| 147 | MP0010771_integument_phenotype | 0.88393241 |
| 148 | MP0002452_abnormal_antigen_presenting | 0.87954459 |
| 149 | MP0001485_abnormal_pinna_reflex | 0.87545911 |
| 150 | MP0009643_abnormal_urine_homeostasis | 0.87234449 |
| 151 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85756919 |
| 152 | MP0000767_abnormal_smooth_muscle | 0.84374989 |
| 153 | MP0000747_muscle_weakness | 0.84121094 |
| 154 | MP0000465_gastrointestinal_hemorrhage | 0.83527770 |
| 155 | MP0005595_abnormal_vascular_smooth | 0.83223852 |
| 156 | MP0000249_abnormal_blood_vessel | 0.82017719 |
| 157 | MP0003631_nervous_system_phenotype | 0.81170244 |
| 158 | * MP0002128_abnormal_blood_circulation | 0.80932697 |
| 159 | MP0002166_altered_tumor_susceptibility | 0.80259495 |
| 160 | * MP0005369_muscle_phenotype | 0.79982571 |
| 161 | MP0000427_abnormal_hair_cycle | 0.79866844 |
| 162 | MP0000372_irregular_coat_pigmentation | 0.79815786 |
| 163 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79652376 |
| 164 | MP0005451_abnormal_body_composition | 0.79185171 |
| 165 | MP0005319_abnormal_enzyme/_coenzyme | 0.78291903 |
| 166 | MP0003724_increased_susceptibility_to | 0.76904518 |
| 167 | MP0009379_abnormal_foot_pigmentation | 0.76437775 |
| 168 | MP0008004_abnormal_stomach_pH | 0.76182159 |
| 169 | MP0000759_abnormal_skeletal_muscle | 0.76078376 |
| 170 | MP0005166_decreased_susceptibility_to | 0.76054021 |
| 171 | MP0005666_abnormal_adipose_tissue | 0.75950071 |
| 172 | MP0002909_abnormal_adrenal_gland | 0.73089336 |
| 173 | MP0008995_early_reproductive_senescence | 0.72460810 |
| 174 | MP0009764_decreased_sensitivity_to | 0.71859961 |
| 175 | MP0001666_abnormal_nutrient_absorption | 0.71209597 |
| 176 | MP0003690_abnormal_glial_cell | 0.70619324 |
| 177 | MP0004145_abnormal_muscle_electrophysio | 0.69187002 |
| 178 | * MP0000266_abnormal_heart_morphology | 0.66324570 |
| 179 | MP0002735_abnormal_chemical_nociception | 0.66031349 |
| 180 | MP0003075_altered_response_to | 0.65814104 |
| 181 | MP0001765_abnormal_ion_homeostasis | 0.64657119 |
| 182 | MP0003300_gastrointestinal_ulcer | 0.63411391 |
| 183 | MP0002234_abnormal_pharynx_morphology | 0.61522978 |
| 184 | MP0004043_abnormal_pH_regulation | 0.59442557 |
| 185 | MP0004883_abnormal_blood_vessel | 0.55621787 |
| 186 | MP0000609_abnormal_liver_physiology | 0.55200317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.48656234 |
| 2 | Ventricular tachycardia (HP:0004756) | 5.28686176 |
| 3 | Right ventricular cardiomyopathy (HP:0011663) | 5.07218120 |
| 4 | Hemiplegia (HP:0002301) | 4.72535133 |
| 5 | Syncope (HP:0001279) | 4.57616945 |
| 6 | Hemiparesis (HP:0001269) | 4.55065806 |
| 7 | Ventricular fibrillation (HP:0001663) | 4.49481754 |
| 8 | Atrial fibrillation (HP:0005110) | 4.29977519 |
| 9 | Increased IgE level (HP:0003212) | 4.27353275 |
| 10 | Erythroderma (HP:0001019) | 4.17281186 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 4.04612265 |
| 12 | Primary atrial arrhythmia (HP:0001692) | 4.03835859 |
| 13 | Focal motor seizures (HP:0011153) | 3.86792482 |
| 14 | Calf muscle hypertrophy (HP:0008981) | 3.86446215 |
| 15 | Supraventricular tachycardia (HP:0004755) | 3.83415379 |
| 16 | Supraventricular arrhythmia (HP:0005115) | 3.78279001 |
| 17 | Exercise-induced myalgia (HP:0003738) | 3.70712426 |
| 18 | Polycythemia (HP:0001901) | 3.69025207 |
| 19 | Abnormality of binocular vision (HP:0011514) | 3.63163870 |
| 20 | Diplopia (HP:0000651) | 3.63163870 |
| 21 | Prolonged QT interval (HP:0001657) | 3.60863101 |
| 22 | Palmar hyperkeratosis (HP:0010765) | 3.55747261 |
| 23 | Palmoplantar hyperkeratosis (HP:0000972) | 3.55323903 |
| 24 | T lymphocytopenia (HP:0005403) | 3.51447324 |
| 25 | Palpitations (HP:0001962) | 3.51039947 |
| 26 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.46464000 |
| 27 | Lipoatrophy (HP:0100578) | 3.44235737 |
| 28 | Ventricular arrhythmia (HP:0004308) | 3.42368875 |
| 29 | Febrile seizures (HP:0002373) | 3.38530210 |
| 30 | Congenital stationary night blindness (HP:0007642) | 3.38021915 |
| 31 | Exercise-induced muscle cramps (HP:0003710) | 3.37510036 |
| 32 | Abnormality of T cell number (HP:0011839) | 3.34572421 |
| 33 | Myoglobinuria (HP:0002913) | 3.30530519 |
| 34 | Parakeratosis (HP:0001036) | 3.24899655 |
| 35 | Deep venous thrombosis (HP:0002625) | 3.23960488 |
| 36 | Erythema (HP:0010783) | 3.18717491 |
| 37 | Bundle branch block (HP:0011710) | 3.18107768 |
| 38 | Muscle fiber splitting (HP:0003555) | 3.17664331 |
| 39 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.15612029 |
| 40 | Autoimmune hemolytic anemia (HP:0001890) | 3.12292122 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 3.11500598 |
| 42 | Abnormality of the calf musculature (HP:0001430) | 3.09167701 |
| 43 | Cerebral hemorrhage (HP:0001342) | 3.08197657 |
| 44 | Dilated cardiomyopathy (HP:0001644) | 3.05156959 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.98126287 |
| 46 | Hypoglycemic coma (HP:0001325) | 2.98121950 |
| 47 | Hypoproteinemia (HP:0003075) | 2.97645410 |
| 48 | Asymmetric septal hypertrophy (HP:0001670) | 2.95526212 |
| 49 | Hyperactive renin-angiotensin system (HP:0000841) | 2.95448401 |
| 50 | Atrioventricular block (HP:0001678) | 2.94642462 |
| 51 | Heart block (HP:0012722) | 2.94628630 |
| 52 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.93332937 |
| 53 | Conjunctival hamartoma (HP:0100780) | 2.91401024 |
| 54 | Myotonia (HP:0002486) | 2.91174564 |
| 55 | Abnormality of the axillary hair (HP:0100134) | 2.88641095 |
| 56 | Abnormality of secondary sexual hair (HP:0009888) | 2.88641095 |
| 57 | Subaortic stenosis (HP:0001682) | 2.84731539 |
| 58 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.84731539 |
| 59 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.81561667 |
| 60 | Abnormal atrioventricular conduction (HP:0005150) | 2.78638672 |
| 61 | Decreased central vision (HP:0007663) | 2.72276747 |
| 62 | Abnormality of T cells (HP:0002843) | 2.71342022 |
| 63 | Plantar hyperkeratosis (HP:0007556) | 2.69854564 |
| 64 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.69795218 |
| 65 | IgG deficiency (HP:0004315) | 2.69520896 |
| 66 | Ketoacidosis (HP:0001993) | 2.67946009 |
| 67 | Acute encephalopathy (HP:0006846) | 2.67668207 |
| 68 | Gangrene (HP:0100758) | 2.66635751 |
| 69 | Hypotrichosis (HP:0001006) | 2.63635703 |
| 70 | Acute necrotizing encephalopathy (HP:0006965) | 2.60144646 |
| 71 | Abnormality of midbrain morphology (HP:0002418) | 2.58753323 |
| 72 | Molar tooth sign on MRI (HP:0002419) | 2.58753323 |
| 73 | Focal seizures (HP:0007359) | 2.58610008 |
| 74 | Pancreatic cysts (HP:0001737) | 2.55623426 |
| 75 | EMG: myopathic abnormalities (HP:0003458) | 2.55128861 |
| 76 | Abolished electroretinogram (ERG) (HP:0000550) | 2.55015849 |
| 77 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.55000335 |
| 78 | Hematochezia (HP:0002573) | 2.53037042 |
| 79 | True hermaphroditism (HP:0010459) | 2.52989974 |
| 80 | Abnormal EKG (HP:0003115) | 2.51439720 |
| 81 | Hypoplastic left heart (HP:0004383) | 2.50365540 |
| 82 | Abnormality of nail color (HP:0100643) | 2.48354346 |
| 83 | Hyperammonemia (HP:0001987) | 2.48299459 |
| 84 | Visual hallucinations (HP:0002367) | 2.47831405 |
| 85 | Palmoplantar keratoderma (HP:0000982) | 2.46166670 |
| 86 | Pustule (HP:0200039) | 2.45924263 |
| 87 | Abnormality of the nasal mucosa (HP:0000433) | 2.45488012 |
| 88 | Double outlet right ventricle (HP:0001719) | 2.41575382 |
| 89 | Congenital malformation of the right heart (HP:0011723) | 2.41575382 |
| 90 | Hepatic necrosis (HP:0002605) | 2.40949409 |
| 91 | Cerebral edema (HP:0002181) | 2.40895027 |
| 92 | Stomatitis (HP:0010280) | 2.40008171 |
| 93 | Sudden cardiac death (HP:0001645) | 2.39727503 |
| 94 | Respiratory distress (HP:0002098) | 2.39188253 |
| 95 | Muscle stiffness (HP:0003552) | 2.38393574 |
| 96 | Global brain atrophy (HP:0002283) | 2.37209764 |
| 97 | Ketosis (HP:0001946) | 2.35877337 |
| 98 | Thyroiditis (HP:0100646) | 2.34743649 |
| 99 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.33683177 |
| 100 | Progressive macrocephaly (HP:0004481) | 2.33336658 |
| 101 | Pheochromocytoma (HP:0002666) | 2.33082005 |
| 102 | Cavernous hemangioma (HP:0001048) | 2.32310762 |
| 103 | Stomach cancer (HP:0012126) | 2.28005370 |
| 104 | Broad metatarsal (HP:0001783) | 2.26504527 |
| 105 | Spontaneous hematomas (HP:0007420) | 2.25451078 |
| 106 | Pancreatic fibrosis (HP:0100732) | 2.24907200 |
| 107 | Corneal erosion (HP:0200020) | 2.23540874 |
| 108 | Visceral angiomatosis (HP:0100761) | 2.23244685 |
| 109 | Panhypogammaglobulinemia (HP:0003139) | 2.22496901 |
| 110 | Tachypnea (HP:0002789) | 2.22106235 |
| 111 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.21056229 |
| 112 | Split foot (HP:0001839) | 2.20851366 |
| 113 | Severe combined immunodeficiency (HP:0004430) | 2.19683587 |
| 114 | Agammaglobulinemia (HP:0004432) | 2.16374412 |
| 115 | Xanthomatosis (HP:0000991) | 2.16229990 |
| 116 | Renal cortical cysts (HP:0000803) | 2.15849362 |
| 117 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.15361886 |
| 118 | Hypergammaglobulinemia (HP:0010702) | 2.14764745 |
| 119 | Atonic seizures (HP:0010819) | 2.11777225 |
| 120 | Furrowed tongue (HP:0000221) | 2.10642561 |
| 121 | Distal lower limb muscle weakness (HP:0009053) | 2.10592840 |
| 122 | Hypothermia (HP:0002045) | 2.10592268 |
| 123 | Abnormality of eosinophils (HP:0001879) | 2.10282062 |
| 124 | Oral leukoplakia (HP:0002745) | 2.09405728 |
| 125 | Abnormality of the prostate (HP:0008775) | 2.09184521 |
| 126 | Alveolar cell carcinoma (HP:0006519) | 2.08680122 |
| 127 | Mitochondrial inheritance (HP:0001427) | 2.08639930 |
| 128 | Hyperkalemia (HP:0002153) | 2.07619742 |
| 129 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.07489058 |
| 130 | Dicarboxylic aciduria (HP:0003215) | 2.07489058 |
| 131 | Hyperlipoproteinemia (HP:0010980) | 2.07467508 |
| 132 | Action tremor (HP:0002345) | 2.06220768 |
| 133 | Chronic diarrhea (HP:0002028) | 2.05324425 |
| 134 | Chronic bronchitis (HP:0004469) | 2.03751423 |
| 135 | Increased connective tissue (HP:0009025) | 2.03635044 |
| 136 | Abnormal biliary tract physiology (HP:0012439) | 2.03197544 |
| 137 | Bile duct proliferation (HP:0001408) | 2.03197544 |
| 138 | Neuroendocrine neoplasm (HP:0100634) | 2.01710425 |
| 139 | Respiratory failure (HP:0002878) | 2.01454434 |
| 140 | Attenuation of retinal blood vessels (HP:0007843) | 2.01440534 |
| 141 | Hyperglycinuria (HP:0003108) | 2.00074110 |
| 142 | Increased muscle lipid content (HP:0009058) | 1.99422351 |
| 143 | Abnormality of the renal cortex (HP:0011035) | 1.98470598 |
| 144 | Esophageal varix (HP:0002040) | 1.97987280 |
| 145 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.97563068 |
| 146 | Hemangiomatosis (HP:0007461) | 1.97270489 |
| 147 | Intrahepatic cholestasis (HP:0001406) | 1.96775288 |
| 148 | Thick nail (HP:0001805) | 1.96545445 |
| 149 | Abnormality of T cell physiology (HP:0011840) | 1.96020088 |
| 150 | Rhabdomyolysis (HP:0003201) | 1.95644513 |
| 151 | Progressive cerebellar ataxia (HP:0002073) | 1.95550432 |
| 152 | Hyperventilation (HP:0002883) | 1.95513399 |
| 153 | Hepatocellular necrosis (HP:0001404) | 1.95348983 |
| 154 | Metabolic acidosis (HP:0001942) | 1.94811189 |
| 155 | Epileptic encephalopathy (HP:0200134) | 1.94473682 |
| 156 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.94110552 |
| 157 | Eosinophilia (HP:0001880) | 1.93818412 |
| 158 | Neonatal death (HP:0003811) | 1.93297502 |
| 159 | Foot dorsiflexor weakness (HP:0009027) | 1.92782265 |
| 160 | Potter facies (HP:0002009) | 1.92737517 |
| 161 | Facial shape deformation (HP:0011334) | 1.92737517 |
| 162 | Decreased circulating renin level (HP:0003351) | 1.92373510 |
| 163 | Gaze-evoked nystagmus (HP:0000640) | 1.91595668 |
| 164 | Difficulty running (HP:0009046) | 1.90874493 |
| 165 | Dysdiadochokinesis (HP:0002075) | 1.90489202 |
| 166 | Recurrent cutaneous fungal infections (HP:0011370) | 1.89889843 |
| 167 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.89889843 |
| 168 | Abnormality of the foot musculature (HP:0001436) | 1.89031632 |
| 169 | Myokymia (HP:0002411) | 1.88075234 |
| 170 | Abnormality of glycine metabolism (HP:0010895) | 1.86933568 |
| 171 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.86933568 |
| 172 | Abnormality of the renal collecting system (HP:0004742) | 1.86776409 |
| 173 | Hamartoma of the eye (HP:0010568) | 1.86438783 |
| 174 | Dialeptic seizures (HP:0011146) | 1.86378488 |
| 175 | Recurrent bronchitis (HP:0002837) | 1.85799883 |
| 176 | Megalencephaly (HP:0001355) | 1.85530314 |
| 177 | Encephalitis (HP:0002383) | 1.85283556 |
| 178 | Generalized tonic-clonic seizures (HP:0002069) | 1.84502180 |
| 179 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.84370957 |
| 180 | Ragged-red muscle fibers (HP:0003200) | 1.82049252 |
| 181 | Increased cerebral lipofuscin (HP:0011813) | 1.81604696 |
| 182 | Complement deficiency (HP:0004431) | 1.81414541 |
| 183 | Medial flaring of the eyebrow (HP:0010747) | 1.79820901 |
| 184 | Left ventricular hypertrophy (HP:0001712) | 1.79568139 |
| 185 | Hyperglycinemia (HP:0002154) | 1.76899411 |
| 186 | Fragile nails (HP:0001808) | 1.75589235 |
| 187 | Onycholysis (HP:0001806) | 1.74965546 |
| 188 | Recurrent skin infections (HP:0001581) | 1.72263915 |
| 189 | Nephronophthisis (HP:0000090) | 1.72162059 |
| 190 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.71625551 |
| 191 | Absence seizures (HP:0002121) | 1.71237154 |
| 192 | Hypokalemic alkalosis (HP:0001949) | 1.70175074 |
| 193 | Truncal ataxia (HP:0002078) | 1.70081288 |
| 194 | Keratoconus (HP:0000563) | 1.70020750 |
| 195 | Increased corneal curvature (HP:0100692) | 1.70020750 |
| 196 | Impaired smooth pursuit (HP:0007772) | 1.69869749 |
| 197 | Chronic otitis media (HP:0000389) | 1.68807123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.25548599 |
| 2 | TIE1 | 4.13663040 |
| 3 | LMTK2 | 4.10834901 |
| 4 | FRK | 3.32990721 |
| 5 | MYLK | 3.26865040 |
| 6 | TAOK3 | 3.21144497 |
| 7 | TTN | 2.89236977 |
| 8 | TRIB3 | 2.81495136 |
| 9 | STK24 | 2.59308071 |
| 10 | PHKG2 | 2.50869103 |
| 11 | PHKG1 | 2.50869103 |
| 12 | PKN2 | 2.22922029 |
| 13 | ADRBK2 | 2.21935423 |
| 14 | FES | 2.02974322 |
| 15 | EPHB1 | 2.02346382 |
| 16 | CASK | 1.98006107 |
| 17 | MAP4K2 | 1.88408853 |
| 18 | MAP4K1 | 1.81394064 |
| 19 | TGFBR2 | 1.81219796 |
| 20 | EPHB2 | 1.75703647 |
| 21 | RIPK1 | 1.72929354 |
| 22 | BMPR2 | 1.72468815 |
| 23 | DMPK | 1.71472015 |
| 24 | MAPK13 | 1.66278997 |
| 25 | MAP3K2 | 1.61813440 |
| 26 | GRK7 | 1.56321695 |
| 27 | BMPR1B | 1.56151269 |
| 28 | PRKD1 | 1.48831315 |
| 29 | FGFR4 | 1.48143764 |
| 30 | NUAK1 | 1.46673607 |
| 31 | OBSCN | 1.45004346 |
| 32 | PDK3 | 1.44043203 |
| 33 | PDK4 | 1.44043203 |
| 34 | LRRK2 | 1.42596929 |
| 35 | PIK3CA | 1.42400875 |
| 36 | EPHA4 | 1.41810368 |
| 37 | TNK2 | 1.39674964 |
| 38 | ILK | 1.37085458 |
| 39 | BCKDK | 1.32970701 |
| 40 | SYK | 1.28364186 |
| 41 | WNK4 | 1.27542996 |
| 42 | FER | 1.26119177 |
| 43 | PINK1 | 1.24574145 |
| 44 | GRK5 | 1.20210363 |
| 45 | MAP3K13 | 1.20138938 |
| 46 | KIT | 1.19559362 |
| 47 | STK39 | 1.19388019 |
| 48 | ERN1 | 1.19386595 |
| 49 | KSR2 | 1.18995231 |
| 50 | LIMK1 | 1.14836852 |
| 51 | PTK6 | 1.07320899 |
| 52 | PAK3 | 1.06082624 |
| 53 | PDK2 | 1.05193854 |
| 54 | MST4 | 1.03166475 |
| 55 | MAPKAPK3 | 1.03066972 |
| 56 | MARK1 | 1.03003210 |
| 57 | NTRK2 | 1.02513050 |
| 58 | MUSK | 1.01131605 |
| 59 | IKBKB | 1.00693694 |
| 60 | MAP3K3 | 0.98190878 |
| 61 | CSNK1G3 | 0.97057451 |
| 62 | CAMKK2 | 0.96653513 |
| 63 | JAK1 | 0.95202264 |
| 64 | CDC42BPA | 0.94695467 |
| 65 | WNK1 | 0.93084580 |
| 66 | CSNK1G2 | 0.92856987 |
| 67 | FGFR2 | 0.92672543 |
| 68 | DAPK1 | 0.91626263 |
| 69 | ROCK1 | 0.91075209 |
| 70 | CSNK1A1L | 0.90625053 |
| 71 | PAK6 | 0.89424494 |
| 72 | LCK | 0.89112073 |
| 73 | RET | 0.88476526 |
| 74 | TEC | 0.87890587 |
| 75 | SCYL2 | 0.85498952 |
| 76 | EPHA3 | 0.85248158 |
| 77 | PRKCH | 0.84552979 |
| 78 | DAPK3 | 0.84020215 |
| 79 | MAP3K1 | 0.83735127 |
| 80 | DAPK2 | 0.83283600 |
| 81 | KDR | 0.82735059 |
| 82 | NEK9 | 0.81606394 |
| 83 | PDPK1 | 0.81287954 |
| 84 | TESK2 | 0.81014652 |
| 85 | IKBKE | 0.80803168 |
| 86 | STK38 | 0.80117575 |
| 87 | PLK2 | 0.78661078 |
| 88 | SIK1 | 0.78323404 |
| 89 | MAPK12 | 0.77041393 |
| 90 | PDGFRA | 0.74924325 |
| 91 | PIK3CG | 0.74835856 |
| 92 | CSNK1G1 | 0.74332555 |
| 93 | MAP3K4 | 0.73652454 |
| 94 | PRKG2 | 0.73222031 |
| 95 | MAP3K7 | 0.72872169 |
| 96 | MST1R | 0.72268901 |
| 97 | ROCK2 | 0.69994276 |
| 98 | TGFBR1 | 0.69969357 |
| 99 | WNK3 | 0.69543598 |
| 100 | CCNB1 | 0.67653840 |
| 101 | GRK1 | 0.66661893 |
| 102 | OXSR1 | 0.65186689 |
| 103 | MAP2K3 | 0.65044713 |
| 104 | CAMK2D | 0.65001029 |
| 105 | PRKCQ | 0.64445295 |
| 106 | PRKCE | 0.63296670 |
| 107 | MAP3K12 | 0.62856832 |
| 108 | FGFR3 | 0.62798825 |
| 109 | CSK | 0.62196206 |
| 110 | DYRK1A | 0.61508127 |
| 111 | INSRR | 0.61285691 |
| 112 | MAP3K14 | 0.60931328 |
| 113 | PKN1 | 0.60563850 |
| 114 | LYN | 0.60459326 |
| 115 | JAK2 | 0.60071340 |
| 116 | MAP2K4 | 0.59275707 |
| 117 | IGF1R | 0.57203786 |
| 118 | TESK1 | 0.57057306 |
| 119 | PRKCA | 0.56165445 |
| 120 | CAMKK1 | 0.56087770 |
| 121 | PRKCG | 0.55964878 |
| 122 | MAP2K6 | 0.55609129 |
| 123 | MINK1 | 0.54042203 |
| 124 | FGFR1 | 0.54032741 |
| 125 | CAMK2G | 0.53659894 |
| 126 | FYN | 0.53306958 |
| 127 | ITK | 0.53288861 |
| 128 | ACVR1B | 0.53038811 |
| 129 | TRPM7 | 0.52918947 |
| 130 | PRKD3 | 0.52155670 |
| 131 | STK38L | 0.51541092 |
| 132 | MAPK7 | 0.51229255 |
| 133 | PDK1 | 0.51152009 |
| 134 | MAP3K11 | 0.50770860 |
| 135 | PRKACG | 0.49339384 |
| 136 | MAPKAPK5 | 0.49122524 |
| 137 | SGK494 | 0.47934999 |
| 138 | SGK223 | 0.47934999 |
| 139 | PRKAA2 | 0.47199232 |
| 140 | BTK | 0.46367890 |
| 141 | CAMK2A | 0.46284708 |
| 142 | CSNK1A1 | 0.45518151 |
| 143 | SGK1 | 0.45370839 |
| 144 | PRKACA | 0.45266299 |
| 145 | PTK2B | 0.45144847 |
| 146 | CAMK4 | 0.44817579 |
| 147 | TBK1 | 0.44493505 |
| 148 | CDK5 | 0.43441919 |
| 149 | TYK2 | 0.43386689 |
| 150 | JAK3 | 0.43062314 |
| 151 | SGK2 | 0.42408228 |
| 152 | NTRK1 | 0.42084222 |
| 153 | PDGFRB | 0.41458646 |
| 154 | MAP2K2 | 0.40352481 |
| 155 | NTRK3 | 0.39531619 |
| 156 | STK10 | 0.39462540 |
| 157 | NEK1 | 0.38455661 |
| 158 | EGFR | 0.37495283 |
| 159 | ADRBK1 | 0.37384885 |
| 160 | GSK3A | 0.36665559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.20014523 |
| 2 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 3.18321049 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.92301329 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.91253409 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.87444518 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.80659781 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.79796989 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.77374440 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.76933373 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.52969015 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.51107202 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.32748663 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 2.32675586 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.28324413 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26564550 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.21225893 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.15715576 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 2.13802414 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.10669946 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 2.08769493 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.06543515 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.99000722 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.98578947 |
| 24 | Nicotine addiction_Homo sapiens_hsa05033 | 1.96834306 |
| 25 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.92484155 |
| 26 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.85047512 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.84778952 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.82631723 |
| 29 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.80207373 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.66625300 |
| 31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.59969290 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.59182665 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.56779824 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.56605178 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.55480818 |
| 36 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.54864806 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.53793547 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.49917818 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.49761967 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 1.49404313 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.48831409 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.47891667 |
| 43 | Huntingtons disease_Homo sapiens_hsa05016 | 1.46153358 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.39029327 |
| 45 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.36424015 |
| 46 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.35789982 |
| 47 | Olfactory transduction_Homo sapiens_hsa04740 | 1.35606651 |
| 48 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.33689043 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.31758564 |
| 50 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.30895154 |
| 51 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.28455527 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.24944565 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22822000 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18821136 |
| 55 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.15313385 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 1.14954448 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14432535 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12961198 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11988871 |
| 60 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.11421388 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.10849378 |
| 62 | Bile secretion_Homo sapiens_hsa04976 | 1.10324179 |
| 63 | Long-term depression_Homo sapiens_hsa04730 | 1.10003815 |
| 64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09926660 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.08851900 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07014713 |
| 67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.06525013 |
| 68 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.05798686 |
| 69 | Asthma_Homo sapiens_hsa05310 | 1.04968030 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02044171 |
| 71 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01439108 |
| 72 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.00594374 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98119838 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.97531996 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96177286 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85384219 |
| 77 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.83945048 |
| 78 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83564309 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81607153 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.81147291 |
| 81 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.81034621 |
| 82 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79943905 |
| 83 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.78754057 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76206003 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75889643 |
| 86 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74020199 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71643169 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71091641 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.71008118 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.70392992 |
| 91 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.70389110 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66649416 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.66589012 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66383170 |
| 95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64707324 |
| 96 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.62300726 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62172320 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62164131 |
| 99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61921789 |
| 100 | Taste transduction_Homo sapiens_hsa04742 | 0.60376581 |
| 101 | Tight junction_Homo sapiens_hsa04530 | 0.60275079 |
| 102 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59866726 |
| 103 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59823741 |
| 104 | ABC transporters_Homo sapiens_hsa02010 | 0.59417131 |
| 105 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59328465 |
| 106 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58308772 |
| 107 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58154479 |
| 108 | Salivary secretion_Homo sapiens_hsa04970 | 0.55274131 |
| 109 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55199486 |
| 110 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.54278010 |
| 111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52180538 |
| 112 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51867467 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.50244538 |
| 114 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50133159 |
| 115 | Protein export_Homo sapiens_hsa03060 | 0.50026790 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49856191 |
| 117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49314071 |
| 118 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48981630 |
| 119 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47201497 |
| 120 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46410991 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45132770 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45102068 |
| 123 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43148927 |
| 124 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43085889 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.42769110 |
| 126 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41026150 |
| 127 | Cocaine addiction_Homo sapiens_hsa05030 | 0.40999083 |
| 128 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39329411 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39322379 |
| 130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39097536 |
| 131 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.39020402 |
| 132 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.37268607 |
| 133 | Prion diseases_Homo sapiens_hsa05020 | 0.36826066 |
| 134 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36323188 |
| 135 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35595833 |
| 136 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35260705 |
| 137 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34754255 |
| 138 | Insulin secretion_Homo sapiens_hsa04911 | 0.34625901 |
| 139 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33659683 |
| 140 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.33143301 |
| 141 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.32532928 |
| 142 | Mineral absorption_Homo sapiens_hsa04978 | 0.32357070 |
| 143 | Adherens junction_Homo sapiens_hsa04520 | 0.32291138 |
| 144 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30270419 |
| 145 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30168832 |
| 146 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.28971447 |
| 147 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.28964075 |
| 148 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28308589 |
| 149 | Platelet activation_Homo sapiens_hsa04611 | 0.27741195 |
| 150 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26116748 |
| 151 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26061241 |
| 152 | Pertussis_Homo sapiens_hsa05133 | 0.25725018 |
| 153 | Circadian entrainment_Homo sapiens_hsa04713 | 0.25049808 |
| 154 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24503129 |
| 155 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.23809879 |
| 156 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.23271231 |

